Condition

Newly Diagnosed Multiple Myeloma (NDMM) clinical trials and research

• 6Clinical trials
• 1New in 30 days
• 20Countries

Newest Newly Diagnosed Multiple Myeloma (NDMM) clinical trials

All recruiting trials (6)

• Fewer-doses daratumumab added to VRd for newly diagnosed multiple myeloma

  This study tests whether a less-frequent daratumumab dosing plan added to VRd can help patients with newly diagnosed multiple myeloma achieve more MRD negativity.

  Recruiting Phase 2 Tata Memorial Centre · Navi Mumbai, Maharashtra and 1 other locations · NCT07891923

• AZD0120 consolidation vs ASCT in transplant-eligible newly diagnosed multiple myeloma

  This study tests whether AZD0120 given as consolidation can work as well as or better than traditional autologous stem cell transplant in transplant-eligible patients with newly diagnosed multiple myeloma.

  Recruiting at 2 sites Phase 3 AstraZeneca · Gilbert, Arizona and 113 other locations · NCT07735637

• First-line RN1201 CAR-T for newly diagnosed multiple myeloma

  This early, small study tests a once-dosed, donor-derived CAR-T therapy (RN1201) in adults with newly diagnosed multiple myeloma to see if it is safe and if patients respond.

  Recruiting Phase 1 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07652138

• First-line immunotherapy in Chinese adults with newly diagnosed multiple myeloma

  This study will test how first-line immunotherapy treatments—including anti-CD38 antibodies, proteasome inhibitors, and IMiDs—work in adults newly diagnosed with multiple myeloma in China over one year.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07296627

• Combining PET scans and bone marrow genetic testing to better predict relapse in newly diagnosed multiple myeloma patients

  This project tries combining FDG PET/LDCT imaging and whole-exome sequencing of bone marrow to detect minimal residual disease and better predict progression for transplant-eligible newly diagnosed multiple myeloma patients.

  Recruiting at 4 sites Universiteit Antwerpen · Antwerp, Antwerpen and 3 other locations · NCT07087964

• Using 18F-fluciclovine PET/CT to detect multiple myeloma

  This study is testing a new imaging method using a special tracer to see if it can better detect multiple myeloma in adults compared to the current method.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06103838

Related topics

Quick answers

How many Newly Diagnosed Multiple Myeloma (NDMM) clinical trials are recruiting right now?

6, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 20 countries. The most sites are in China (3 trials), United States (2 trials), India (1 trial), Australia (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →